Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant.

Benotmane, Ilies; Velay, Aurélie; Gautier-Vargas, Gabriela; Olagne, Jérôme; Thaunat, Olivier; Fafi-Kremer, Samira; Caillard, Sophie

Benotmane, Ilies; Velay, Aurélie; Gautier-Vargas, Gabriela; Olagne, Jérôme; Thaunat, Olivier; Fafi-Kremer, Samira; Caillard, Sophie.

Afiliação

Benotmane I; Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.
Velay A; Department of Transplantation, Nephrology and Clinical Immunology, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France.
Gautier-Vargas G; Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.
Olagne J; Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.
Thaunat O; Department of Transplantation, Nephrology and Clinical Immunology, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France.
Fafi-Kremer S; Department of Virology, Strasbourg University Hospital, Strasbourg, France.
Caillard S; Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France. Electronic address: Sophie.caillard@chru-strasbourg.fr.

Kidney Int ; 102(2): 442-444, 2022 08.

Article em En | MEDLINE | ID: mdl-35618094

Assuntos

Infecções por HIV; Profilaxia Pré-Exposição; Anticorpos Neutralizantes; Anticorpos Antivirais; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Profilaxia Pré-Exposição Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google